Literature DB >> 11463925

Diagnosis of human papillomavirus infection by dry vaginal swabs in military women.

K V Shah1, R W Daniel, M K Tennant, N Shah, K T McKee, C A Gaydos, J C Gaydos, A Rompalo.   

Abstract

OBJECTIVE: Human papillomavirus (HPV) assays are likely to be used with increasing frequency in clinical management of women with abnormal Papanicolaou smears and in cervical cancer screening. Our objective was to simplify the method of collection of female genital tract specimens. The utility of vaginal dry swabs for HPV diagnosis was evaluated.
METHODS: Specimens for cytology and for HPV identification were collected by a clinician from 189 female soldiers attending a military clinic. Three methods of specimen collection for HPV identification were compared: a vaginal dry swab (v-DRY), and vaginal and cervical swabs placed into specimen transport medium (v-STM and c-STM). Swabs were shipped to a STD laboratory for processing. Specific HPV types were identified by a consensus primer based PCR based method. Results from 165 women were evaluable.
RESULTS: HPV prevalence by the three methods was similar and ranged from 44.8% to 50.9%. 53 (32.1%) women were HPV positive and 60 (36.4%) women were HPV negative by all three collection methods. With respect to the risk categories of specific HPV types, there was greater agreement between the results from the two vaginal (v-DRY and v-STM) samples (kappa values of 0.69-0.81) than between the cervical (c-STM) and either of the vaginal samples (kappa values of 0.37-0.55). The HPV yield from c-STM was somewhat greater than that from the vaginal specimens but the correlation between cytological abnormalities and HPV was high for all three methods.
CONCLUSION: A dry vaginal swab may be an acceptable method of specimen collection for HPV diagnosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463925      PMCID: PMC1744351          DOI: 10.1136/sti.77.4.260

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  11 in total

1.  Concurrent and sequential acquisition of different genital human papillomavirus types.

Authors:  K K Thomas; J P Hughes; J M Kuypers; N B Kiviat; S K Lee; D E Adam; L A Koutsky
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

2.  Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay.

Authors:  R W Daniel; L Ahdieh; D Hayden; S Cu-Uvin; K V Shah
Journal:  J Clin Virol       Date:  2000-12       Impact factor: 3.168

3.  HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.

Authors:  T C Wright; L Denny; L Kuhn; A Pollack; A Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Authors:  J W Sellors; A T Lorincz; J B Mahony; I Mielzynska; A Lytwyn; P Roth; M Howard; S Chong; D Daya; W Chapman; M Chernesky
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

7.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

8.  Self-administered home cervicovaginal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections.

Authors:  E A Morrison; G L Goldberg; R J Hagan; A S Kadish; R D Burk
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

9.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

10.  Comparison between methods for human papillomavirus DNA testing: a model for self-testing in young women.

Authors:  A B Moscicki
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

View more
  12 in total

1.  Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population.

Authors:  M Paz Cañadas; F Xavier Bosch; M Luisa Junquera; Maijo Ejarque; Rebeca Font; Elena Ordoñez; Silvia de Sanjosé
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection.

Authors:  Qinghua Feng; Stephen Cherne; Rachel L Winer; Viorica Popov; Hector Zambrano; Carlos Yerovi; Stephen E Hawes; Laura A Koutsky; Nancy B Kiviat
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

3.  High-risk behavior and sexually transmitted infections among U.S. active duty servicewomen and veterans.

Authors:  Vinita Goyal; Kristin M Mattocks; Anne G Sadler
Journal:  J Womens Health (Larchmt)       Date:  2012-09-20       Impact factor: 2.681

4.  Seroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnel.

Authors:  Jennifer Masel; Robert G Deiss; Xun Wang; Jose L Sanchez; Anuradha Ganesan; Grace E Macalino; Joel C Gaydos; Mark G Kortepeter; Brian K Agan
Journal:  Sex Transm Dis       Date:  2015-05       Impact factor: 2.830

5.  A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.

Authors:  Darron R Brown; Marcia L Shew; Brahim Qadadri; Nicole Neptune; Maria Vargas; Wanzhu Tu; Beth E Juliar; Timothy E Breen; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2004-12-10       Impact factor: 5.226

6.  The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases.

Authors:  Charlotte A. Gaydos; Anne M. Rompalo
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

7.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

8.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

9.  Exposure to high-risk genital human papillomavirus and its association with risky sexual practices and laboratory-confirmed chlamydia among African-American women.

Authors:  Puja Seth; Gina M Wingood; Lashun S Robinson; Ralph J Diclemente
Journal:  Womens Health Issues       Date:  2009-08-12

10.  The changing landscape of controlling sexually transmitted infections in the U.S. military.

Authors:  Joel C Gaydos; Kelly T McKee; Charlotte A Gaydos
Journal:  MSMR       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.